Röhm has launched two new additions to its CYROLITE portfolio – CYROLITE acrylic-based copolymer compounds specially developed for medical applications.
According to reports, the new CYROLITE G-20 CP is a PMMA-based copolymer that can be used for injection molding and extrusion processing for UV protection medical applications. It protects the integrity of light sensitive substances such as oncology drugs, antibiotics and antifungals that require UV protection.
The material has the characteristics of low UV light transmittance (<1.0%260-480nm) and high transmittance (500-780 nm). Thomas Spagnuolo, vice president and general manager of molding compounds at Rohm Chemicals America, said the compound's highly flexible properties help in innovative medical device designs.
CYROLITE G-20 CP has high processability and high adhesion characteristics, which is dynamic and adaptable in the design of medical applications. Its impact resistance is unmodified
Five times stronger than acrylic resin, it is highly resistant to body fluids and other chemicals, ensuring industry-leading safety and protection of contents. Another new product, CYROLITE MD
zk6 acrylic polymer, is an amorphous impact-modified thermoplastic injection molding and extrusion compound based on PMMA
substances for the medical device and diagnostic industries. The impact resistance of this product is 3 times that of other MD-grade acrylic resins, and it has high light transmittance and low haze.
High impact resistance and ductility/toughness make it suitable for applications such as dialysis cassettes, test packs, filter housings, microfluidics, luers, tubing connectors, IV catheter hubs and Y-sites.
微信扫一扫打赏
